ACUTE RESPIRATORY VIRAL INFECTIONS IN PREGNANT WOMEN: IMPACT ON THE COURSE AND OUTCOME OF PREGNANCY AND CHILDBIRTH
Main Article Content
Abstract
This article presents data on the impact of acute respiratory viral infections (ARVIs) experienced during gestation on the course and outcome of pregnancy and childbirth.
The aim of the study was to evaluate the impact of ARVIs experienced during pregnancy on the course and outcome of pregnancy and childbirth.
Methods. The study was conducted in 2025. Seventy pregnant women were included. A questionnaire was developed for the participants, containing questions about age, parity, gestational age at which the ARVI was experienced (if any), ARVI symptoms, temperature elevation, treatment methods, hospitalization, and extragenital pathology (stage 1). Then (stage 2), an analysis of obstetric and perinatal outcomes for the same women was conducted. Statistical analysis included the χ² criterion.
Results. The study group included 42 women (60%) who experienced ARVI during pregnancy, and the comparison group included 28 women (40%). Extragenital pathology was significantly more common in the study group (57.1% vs. 35.7%; p < 0.05). The most common complaints associated with acute respiratory viral infections were runny nose (57.1%), nasal congestion (52.4%), and weakness and sore throat (42.9% each). Pregnancy complications were observed in 45.2% of pregnant women in the study group and 39.3% in the comparison group. The cesarean section rate in the study group was 42.9% vs. 25.0% in the comparison group (p > 0.05).
Conclusion. Acute respiratory viral infections (ARVI) suffered during gestation are more often associated with extragenital pathology and increase the incidence of pregnancy complications and operative delivery, requiring timely prevention and comprehensive management of this category of patients.
Keywords
Author Biographies
Elena Nikolaevna Kravchenko,
Doctor of medical sciences, professor, head of chair of obstetrics and gynecology
Anna Vladimirovna Mordyk,
doctor of medical sciences, professor, head of the department of tb, pulmonology and infection deaseses
Ksenia Vyacheslavovna Timofeeva,
resident
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018; 391(10127): 1285-1300. doi: 10.1016/S0140-6736(17)33293-2
2. Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. Am J ReprodImmunol. 2010; 63(6): 425-433. doi: 10.1111/j.1600-0897.2010.00836.x
3. Rasmussen SA, Jamieson DJ. What Obstetric Health Care Providers Need to Know About COVID-19. Obstet Gynecol. 2020; 135(5): 999-1002. doi: 10.1097/AOG.0000000000003816
4. Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021. MMWR Morb Mortal Wkly Rep. 2021; 70: 1013-1019. doi: 10.15585/mmwr.mm7029a1
5. Zheng Q, Li J, Wu Z, Deng Y, Wang Y, Li H, et al. Association between coronavirus disease 2019 in pregnancy and maternal and perinatal outcomes: A systematic review and meta-analysis. BJOG. 2021; 128(13): 2095-2106. doi: 10.1111/1471-0528.16835
6. Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Saade GR, Grobman WA, et al. Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications. JAMA. 2022; 327(8): 748-759. doi: 10.1001/jama.2022.1190
7. Edwards MJ. Review: Hyperthermia and fever during pregnancy. Birth Defects Res. 2021; 113(20): 1479-1487. doi: 10.1002/bdr2.1969
8. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The coronavirus disease 2019 infection in pregnancy and adverse pregnancy outcomes: a systematic review and meta-analysis. Obstet Gynecol Sci. 2023; 66(4): 270-289. doi: 10.5468/ogs.22323
9. Rumfelt KE, Englund JA, Chu HY. The burden, pathogenesis, clinical outcomes, and treatment of common respiratory virus infections during pregnancy. Womens Health (Lond). 2025; 21: 17455057251338501. doi: 10.1177/17455057251338501
10. Prajapati DJ, Patel SV, Panchal NP, Patel RV. Feto maternal outcome in pregnancy with fever. Int J Reprod Contracept Obstet Gynecol. 2024; 13(6): 1405-1411. doi: 10.18203/2320-1770.ijrcog20241434
11. Mongelli M. Influenza and COVID-19 in Pregnancy. O&G Magazine. 2025; 27(4).
12. Kravchenko EN, Pozdnyakov IM, Sokolova TM, Antipova EP, Makarov KYu. Obstetric and perinatal outcomes in pregnant women during the influenza epidemic and acuterespiratory viral infections. Effectiveness of drug prophylaxis. Mother and Baby in Kuzbass. 2026; 2(105): 42-50. Russian (Кравченко Е.Н., Поздняков И.М., Соколова Т.М., Антипова Е.П., Макаров К.Ю. Акушерские и перинатальные исходы у беременных в период эпидемии гриппа и острых респираторных вирусных инфекций. Эффективность медикаментозной профилактики //Мать и Дитя в Кузбассе. 2026. № 2(105). С. 42-50.) doi: 10.24412/2686-7338-2026-2-42-50